173 related articles for article (PubMed ID: 35008508)
1. Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton's Tyrosine Kinase.
Duan R; Goldmann L; Li Y; Weber C; Siess W; von Hundelshausen P
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008508
[TBL] [Abstract][Full Text] [Related]
2. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
Denzinger V; Busygina K; Jamasbi J; Pekrul I; Spannagl M; Weber C; Lorenz R; Siess W
Thromb Haemost; 2019 Mar; 119(3):397-406. PubMed ID: 30685871
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.
Rigg RA; Aslan JE; Healy LD; Wallisch M; Thierheimer ML; Loren CP; Pang J; Hinds MT; Gruber A; McCarty OJ
Am J Physiol Cell Physiol; 2016 Mar; 310(5):C373-80. PubMed ID: 26659727
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.
von Hundelshausen P; Lorenz R; Siess W; Weber C
Thromb Haemost; 2021 Nov; 121(11):1395-1399. PubMed ID: 33851389
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI.
Nicolson PLR; Hughes CE; Watson S; Nock SH; Hardy AT; Watson CN; Montague SJ; Clifford H; Huissoon AP; Malcor JD; Thomas MR; Pollitt AY; Tomlinson MG; Pratt G; Watson SP
Haematologica; 2018 Dec; 103(12):2097-2108. PubMed ID: 30026342
[TBL] [Abstract][Full Text] [Related]
8. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?
Goldmann L; Duan R; Kragh T; Wittmann G; Weber C; Lorenz R; von Hundelshausen P; Spannagl M; Siess W
Blood Adv; 2019 Dec; 3(23):4021-4033. PubMed ID: 31809536
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and
Duan R; Goldmann L; Brandl R; Spannagl M; Weber C; Siess W; von Hundelshausen P
Front Cardiovasc Med; 2021; 8():749022. PubMed ID: 34631841
[No Abstract] [Full Text] [Related]
10. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
11. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.
Oda A; Ikeda Y; Ochs HD; Druker BJ; Ozaki K; Handa M; Ariga T; Sakiyama Y; Witte ON; Wahl MI
Blood; 2000 Mar; 95(5):1663-70. PubMed ID: 10688822
[TBL] [Abstract][Full Text] [Related]
12. Noncatalytic Bruton's tyrosine kinase activates PLCγ
Wist M; Meier L; Gutman O; Haas J; Endres S; Zhou Y; Rösler R; Wiese S; Stilgenbauer S; Hobeika E; Henis YI; Gierschik P; Walliser C
J Biol Chem; 2020 Apr; 295(17):5717-5736. PubMed ID: 32184360
[TBL] [Abstract][Full Text] [Related]
13. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
[TBL] [Abstract][Full Text] [Related]
14. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
15. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.
Gardiner EE; Karunakaran D; Arthur JF; Mu FT; Powell MS; Baker RI; Hogarth PM; Kahn ML; Andrews RK; Berndt MC
Blood; 2008 Jan; 111(1):165-74. PubMed ID: 17848620
[TBL] [Abstract][Full Text] [Related]
16. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
[TBL] [Abstract][Full Text] [Related]
17. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
Arman M; Krauel K
J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
[TBL] [Abstract][Full Text] [Related]
18. A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.
Rijkers M; Saris A; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Bierings R; Leebeek FWG; Jansen AJG; Vidarsson G; Voorberg J; de Haas M
Haematologica; 2018 Oct; 103(10):1741-1752. PubMed ID: 29858387
[TBL] [Abstract][Full Text] [Related]
19. Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction.
Ninomoto J; Mokatrin A; Kinoshita T; Marimpietri C; Barrett TD; Chang BY; Sukbuntherng J; James DF; Crowther M
Hematology; 2020 Dec; 25(1):112-117. PubMed ID: 32131714
[No Abstract] [Full Text] [Related]
20. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen.
Quek LS; Bolen J; Watson SP
Curr Biol; 1998 Oct; 8(20):1137-40. PubMed ID: 9778529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
